Our results indicated that nuclear SMAD4 expression and tumor size were independent significant risk factors affecting the DSS of patients with RCC and ccRCC as the most metastatic subtype in multivariable analysis. This evidence concerns the gene SMAD4 and nonpapillary renal cell carcinoma.